Study of the selective uptake progress of aptamer-modified PLGA particles by liver cells.
about
A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer TherapyEndocytosis in gene therapy with non-viral vectors.Antitumor Activity of a Unique Polymer That Incorporates a Fluorescent Self-Assembled Metallacycle.The Role of Hydrophobicity in the Cellular Uptake of Negatively Charged Macromolecules.Enhanced cellular uptake and tumor penetration of nanoparticles by imprinting the "hidden" part of membrane receptors for targeted drug delivery.Monitoring the intracellular transformation process of surface-cleavable PLGA particles containing disulfide bonds by fluorescence resonance energy transfer
P2860
Study of the selective uptake progress of aptamer-modified PLGA particles by liver cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Study of the selective uptake progress of aptamer-modified PLGA particles by liver cells.
@en
Study of the selective uptake progress of aptamer-modified PLGA particles by liver cells.
@nl
type
label
Study of the selective uptake progress of aptamer-modified PLGA particles by liver cells.
@en
Study of the selective uptake progress of aptamer-modified PLGA particles by liver cells.
@nl
prefLabel
Study of the selective uptake progress of aptamer-modified PLGA particles by liver cells.
@en
Study of the selective uptake progress of aptamer-modified PLGA particles by liver cells.
@nl
P2093
P2860
P356
P1476
Study of the selective uptake progress of aptamer-modified PLGA particles by liver cells.
@en
P2093
Yuying Zhang
Zhengwei Mao
P2860
P304
P356
10.1002/MABI.201300165
P50
P577
2013-07-19T00:00:00Z